Predict your next investment

MoA Technology company logo
INDUSTRIAL | Basic Materials / Agricultural Chemicals
moa-technology.com

See what CB Insights has to offer

Executives

1

Board of Directors

2

MoA Technology Board of Directors

2 Board of directors

MoA Technology has 2 board of directors, including David Lawrence.

Name

Firm

Work History

Other Seats

David Lawrence

KTN, Tropic Biosciences, and UK Innovation & Science Seed Fund

Hadyn Parry

Hadyn Parry is an experienced executive from the biotechnology, life science, and agro-chemical industries. He has experience with building new companies from his time as CEO of Oxitec –the world's first company to use genetically engineered male insects to combat mosquitoes that spread damaging diseases (such as Dengue Fever and Zika virus) and major pests of agricultural crops.

BioPhero, and LettUs Grow

Name

David Lawrence

Hadyn Parry

Firm

Work History

Hadyn Parry is an experienced executive from the biotechnology, life science, and agro-chemical industries. He has experience with building new companies from his time as CEO of Oxitec –the world's first company to use genetically engineered male insects to combat mosquitoes that spread damaging diseases (such as Dengue Fever and Zika virus) and major pests of agricultural crops.

Other Seats

KTN, Tropic Biosciences, and UK Innovation & Science Seed Fund

BioPhero, and LettUs Grow

MoA Technology Management Team

1 Team Member

MoA Technology has 1 executive. MoA Technology's current Chief Technology Officer is Shuji Hachisu.

Name

Work History

Title

Status

Shuji Hachisu

Chief Technology Officer

Current

Name

Shuji Hachisu

Work History

Title

Chief Technology Officer

Status

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.